Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation

Overview of attention for article published in Stem Cell Research & Therapy, September 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study

Preprint in Research Square (January 2024)

Clinical aspects of umbilical cord cannulation during transfer from the uterus to a liquid-based perinatal life support system for extremely premature infants a qualitative generic study

Article in PLOS ONE (December 2023)

Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs

Article in Stem Cell Research & Therapy (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.